Company History

Foregene History

  • 2011
    Foregene was established in April 2011, focused on the development of innovative molecular biology technology and molecular diagnostic products.
  • 2015
    In 2015, Foregene developed the Direct PCR technology and won the National third place in the Innovation and Entrepreneurship Competition of "Going to Silicon Valley to Affect 1 Billion People".
  • 2016
    In 2016, a wholly-owned subsidiary, Fengji Biotechnology, was established, dedicated to the transformation of Direct PCR technology in the field of molecular diagnosis.
  • 2019
    At the end of 2019, the R&D of "15 respiratory system pathogenic bacteria detection kits" was completed.
  • 2020
    In February 2020, the R&D of the "new coronavirus nucleic acid detection kit" was completed.
  • 2020
    In November 2020, it received 5.4 million US dollars in venture capital.